Biochemical Analysis of Caur SOD4, a Potential Therapeutic Target for the Emerging Fungal Pathogen Candida auris

is an emerging multidrug-resistant fungal pathogen. With high mortality rates, there is an urgent need for new antifungals to combat . Possible antifungal targets include Cu-only superoxide dismutases (SODs), extracellular SODs that are unique to fungi and effectively combat the superoxide burst of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ACS infectious diseases 2022-03, Vol.8 (3), p.584-595
Hauptverfasser: Chandler, Courtney E, Hernandez, Francisco G, Totten, Marissa, Robinett, Natalie G, Schatzman, Sabrina S, Zhang, Sean X, Culotta, Valeria C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:is an emerging multidrug-resistant fungal pathogen. With high mortality rates, there is an urgent need for new antifungals to combat . Possible antifungal targets include Cu-only superoxide dismutases (SODs), extracellular SODs that are unique to fungi and effectively combat the superoxide burst of host immunity. Cu-only SODs are essential for the virulence of diverse fungal pathogens; however, little is understood about these enzymes in We show here that secretes an enzymatically active Cu-only SOD ( SOD4) when cells are starved for Fe, a condition mimicking host environments. Although predicted to attach to cell walls, SOD4 is detected as a soluble extracellular enzyme and can act at a distance to remove superoxide. SOD4 selectively binds Cu and not Zn, and Cu binding is labile compared to bimetallic Cu/Zn SODs. Moreover, SOD4 is susceptible to inhibition by various metal-binding drugs that are without effect on mammalian Cu/Zn SODs. Our studies highlight SOD4 as a potential antifungal target worthy of consideration.
ISSN:2373-8227
2373-8227
DOI:10.1021/acsinfecdis.1c00590